osiris therapeutics News
Most Popular osiris therapeutics Story
Osiris shares soar on $1.38B Genzyme pact
Shares of Osiris Therapeutics rocketed up 26 percent after the developer announced that Genzyme had agreed to pay up to $1.38 billion to develop two adult stem cell therapies. Columbia, MD-based... Read more...
Latest Headlines
- November 4, 2008
- October 9, 2007
- August 6, 2006
- May 11, 2006
- December 20, 2005
- June 15, 2005
- June 9, 2005
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
